Interferon gamma inducible protein 10
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
(Redirected from CXCL10)
 | This article is a stub. |
IP-10 is Interferon gamma (INF-γ) inducible protein 10, and is also known as C-X-C Motif Chemokine Ligand 10 or CXCL10.[1] IP-10 is a chemokine, and important for recruiting natural killer cells to the myocardium, and for limiting viral duplication in murine (mice/rodent) coxsackievirus infection.[2]
Alternative names[edit | edit source]
IP-10 is also known as:
- CXCL10[1]
- C-X-C motif chemokine 10[1]
- IFN-γ inducible protein 10[2]
- Interferon gamma inducible protein 10
- 10 kDa interferon-gamma induced protein[3]
Function[edit | edit source]
ME/CFS[edit | edit source]
Notable studies[edit | edit source]
- This study found "compelling evidence" of the role of several cytokines/chemokines in the physiological and cognitive pathology in a group of patients with chronic fatigue syndrome, although these patients were selected using the Oxford criteria, which includes many patients with chronic fatigue not caused by ME/CFS.
Learn more[edit | edit source]
- C-X-C Motif Chemokine Ligand 10 - Gene cards
See also[edit | edit source]
References[edit | edit source]
- ↑ 1.0 1.1 1.2 "CXCL10 - C-X-C motif chemokine 10 precursor - Homo sapiens (Human) - CXCL10 gene & protein". uniprot.org. Retrieved January 24, 2019.
- ↑ 2.0 2.1 Loux, Tara J.; Lotze, Michael T.; Zeh, Herbert J. (January 1, 2010). Lotze, Michael T.; Thomson, Angus W. (eds.). Chapter Fourteen - NK cells as recipients of cytokine signals. San Diego: Academic Press. pp. 189–201. ISBN 9780123704542.
- ↑ Lee, James J.; Rosenberg, Helene F., eds. (January 1, 2013). Chapter 6 - Eosinophil Trafficking. Eosinophils in Health and Disease. Boston: Academic Press. pp. 121–166. ISBN 9780123943859.
- ↑ McArdle, Anne; Gusnanto, Arief; Earl, Kate; Sakellariou, George; Lawton, Clare; Owens, Daniel; Close, Graeme; Beadsworth, Michael; Dye, Louise (April 1, 2017). "The role of IP-10 in Chronic Fatigue Syndrome". The FASEB Journal. 1 (1 supplement): lb789. doi:10.1096/fasebj.31.1_supplement.lb789.
